Why Do Western Governments Keep Folding to China? Nexperia Serves Up Another Example.
The Netherlands is the latest example of a country succumbing to China’s leadership position in critical supply chains.
Senate Witnesses Discuss Reshoring and Making China’s Massive Biotech Ecosystem Less Attractive for Big Pharma
Witnesses at a Senate hearing on Wednesday, Oct. 29 titled “The Future of Biotech” discussed ways to facilitate reshoring and making it attractive to expand in the U.S. and conduct R&D here instead of in China.
With China Agreement Complete, CPA Urges Trump Administration to Prioritize 232 Investigations and Domestic Producers
President Trump has already made the most important deal of his life—his promise to the American people to end U.S. dependence on China and rebuild our domestic industrial capacity.
At Senate Commerce, Bipartisan Support for Shipbuilding Industry. So What is Congress Waiting For?
There are very few things that Democrats and Republicans agree on. One of them is the need to support domestic shipbuilding beyond just military vessels.
CPA Releases New Economics Report on America’s Chip-for-Chip Tariff Policy
The report, titled “America’s Chip-for-Chip Tariff Policy: The Urgent Fight to Reclaim Industrial Independence Before It’s Too Late,” finds that the United States now produces only 10 percent of the world’s chips—and almost none of the most advanced ones—while China has captured the majority of global capacity for legacy chips, the mature semiconductors essential to cars, medical devices, and industrial equipment.
To Reshore Generic Drugs, Use Sugar’s Sweet Model
America is finally getting serious about its dangerous dependence on foreign-made generic drugs.
CPA Submits Section 232 Comments on Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices
The Trump administration’s section 232 investigation into medical devices and personal protective equipment is a vital step toward ensuring America takes back control over its production and domestic supply of critical medical products.
ICYMI: CPA Economist Andrew Rechenberg Stars at Hearing on Fixing America’s Broken Drug Supply Chain
The hearing continued the committee’s efforts to examine and reduce America’s severely dangerous over-dependence on foreign-manufactured generic drugs and address vulnerabilities in the nation’s pharmaceutical supply chain.
GM Tops the List of “Most Exposed to China”
This year, GM swapped positions with Ford. GM is the most exposed to China while Ford has declined to No. 5.
CPA’s Jeff Ferry Teaches the Next Generation How to Rebuild American Industry
CPA’s chief economist emeritus, Jeff Ferry, has gone back to school in his semi-retirement years. This time, though, it was a speaking gig at the University of Florida’s new Semiconductor Institute in Gainesville.
